--- ## Retatrutide FDA Approval Timeline: What to Expect As of July 2026, Eli Lilly's TRIUMPH Phase 3 program is underway with four trials (TRIUMPH-1 through TRIUMPH-4) covering obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis (MASH)
Therefore, it demonstrates significant efficacy in weight loss, blood sugar control, and cardiovascular protection, making it an important treatment option for type 2 diabetes patients and individuals managing their weight
CARMICHAEL: Theyre making it as difficult as possible for people
Decreased Libido Emerging research shows that taking GLP-1 drugs can also have an impact on libido, with some people reporting a lower sex drive
This isn't finasteride or minoxidil, where decades of controlled studies establish clear efficacy benchmarks
PNH clones were found in 46% of patients with AA